Business description
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Management board & Supervisory board
| CEO |
| Daniel O’Day |
| Management board |
| Andrew Dickinson, Jyoti Mehra, Stacey Ma, Flavius Martin, Johanna Mercier, Cindy Perettie, Deborah H. Telman, Merdad Parsey |
| Supervisory board |
| Daniel O’Day, Jacqueline K. Barton, Jeffrey A. Bluestone, Sandra J. Horning, Kelly A. Kramer, Harish Manwani, Anthony Welters, Ted W. Love, Javier J. Rodriguez |
Company data
| Name: |
Gilead Sciences Inc. |
| Address: |
333 Lakeside Drive,Foster City, California 94404, USA |
| Phone: |
+1-650-574-3000 |
| Fax: |
+1-650-578-9264 |
| E-mail: |
corporate_developmen...ad.com
corporate_development@gilead.com
|
| Internet: |
www.gilead.com |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12-31 |
| Free Float: |
55.84% |
| IPO date: |
1992-01-22 |
